The ascendancy of Viagra and its influence on the pharmaceutical landscape presents a intricate question for investors. While the first sales figures were astounding, the exclusivity has expired, leading to a deluge of copycat alternatives that are eroding profit. Moreover, the market is facing difficulties related to demographic trends and evol… Read More